A Chinese data center developer and operator, a pharmaceutical company focused on disorders of the central nervous system, and a developer of software for customer engagement and digital process automation (up 103%, 180% and 62% year-to-date, respectively) comprise the trio of stocks highlighted in today’s article for their “monster growth” prospects from current levels. For these three stocks where Wall Street analysts see significant upside potential, For more, CLICK HERE.
Halloween is over and assorted monster costumes have been put away – but there is still monster growth to be had in certain stocks! Today’s article highlights three stocks “with strong monster growth narratives” – each of which has recently reported impressive earnings numbers and had their price targets increased by some of Wall Street’s top-performing analysts as a result. For these three “monster growth” stocks – all of which have “Strong Buy” consensus ratings and upside potential above 20% – CLICK HERE.